(Q44345895)

2 December 2017

title

Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria (English)

1 reference

2 December 2017

main subject

Gram-negative bacteria

0 references

author name string

Marcela Nastro

1

1 reference

2 December 2017

Carlos Hernan Rodríguez

2

1 reference

2 December 2017

Renata Monge

3

1 reference

2 December 2017

Jonathan Zintgraff

4

1 reference

2 December 2017

Liliana Neira

5

1 reference

2 December 2017

Mirta Rebollo

6

1 reference

2 December 2017

Carlos Vay

7

1 reference

2 December 2017

Angela Famiglietti

8

1 reference

2 December 2017

language of work or name

1 reference

6 December 2013

1 reference

2 December 2017

published in

Journal of Chemotherapy

1 reference

2 December 2017

volume

26

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

211-216

1 reference

Emerging carbapenemases: a global perspective

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Multiplex PCR for detection of acquired carbapenemase genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

In vitro activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Nitazoxanide inhibits biofilm production and hemagglutination by enteroaggregative Escherichia coli strains by blocking assembly of AafA fimbriae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Polymyxin B and Rifampin: New Regimen for Multiresistant Serratia marcescens Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Tigecycline: a first in class glycylcycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947813Y.0000000136

Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp

21 January 2018

1 reference

12 December 2020

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin

1 reference

12 December 2020

In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones.

1 reference

12 December 2020

In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates

1 reference

12 December 2020

Can composition and structural features of oligonucleotides contribute to their wide-scale applicability as random PCR primers in mapping bacterial genome diversity?

1 reference

12 December 2020

Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003

1 reference

12 December 2020

10.1179/1973947813Y.0000000136

Identifiers

DOI

1 reference

2 December 2017

1 reference